the logistics of manufacturing allogeneic therapies on a large scale
Published 2 years ago • 40 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
28:04
gct manufacturing | vector production | autologous and allogeneic | stem cells |supply chain
-
7:36
the biggest challenges in allogeneic cell therapy manufacturing
-
1:18
upscaling cell and gene therapy manufacturing
-
38:13
flexible manufacturing strategies for cell and gene therapy products
-
29:48
allogeneic cell therapies summit may 2021 | dr. ezequiel zylberberg
-
1:24:02
workshop: aligning clinical, manufacturing, and logistics platforms to treat patients at scale
-
11:37
cell therapy manufacturing and economies of scale
-
21:52
cell therapy logistics: exploring the last 100m presentation by dr. chris herbert
-
18:16
moving gene therapies to market: the role of manufacturing technologies
-
55:27
technical tuesday cell and gene therapy looking beyong autologous transitioning to allogeneic
-
11:23
the logistics of building a car-t program
-
2:08
dr. ghobadi discusses the logistics of car t-cell therapy
-
1:17
the importance of analytical tools in cell and gene therapy manufacturing
-
59:22
evolution in the manufacturing of cellular therapies- lessons learned and current solutions
-
1:58
cell & gene therapy trailblazers - process development - chapter 1: ‘diagnose to de-risk’
-
2:52
developing manufacturing systems for cell and gene therapies
-
58:25
panel: current realities of make vs. buy for cell & gene therapy manufacturing
-
40:47
gene therapy manufacturing at-scale with geoff mackay
-
2:25
large-scale cell manufacturing – the clinimacs cell factory®